Back to Trades
Sell4
Moderna, Inc.
MRNA
Total Value
$265.0K
Net $265.0K sold
Sales
$265.0K
1 transaction
Company Information
- Company Name
- Moderna, Inc.
- Ticker Symbol
- MRNA
- CIK
- 0001682852
Insider Information
- Name
- Hussain Abbas
- Role
- Director
- Location
- CAMBRIDGE, MA
Director
Filing Details
- Filing Date
- May 4, 2026
- Transaction Date
- Apr 30, 2026
- Accession Number
- 0001682852-26-000070
- Form Type
- 4
- Net Trading Amount
- -$265.0K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Apr 30, 2026 | Common Stock | 16,233 | — | Exercise | — |
| May 1, 2026 | Common Stock | 5,682 | $46.63 | Sale | $265.0K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Apr 30, 2026 | Derivative | 16,233 | — | Exercise | — |
Footnotes
- (F1)Restricted stock units convert into common stock on a one-for-one basis.
- (F2)This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2025. The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units.
- (F3)The shares subject to this restricted stock unit award vested in full on April 30, 2026.